A short explainer on how these drugs signal fullness and help control blood sugar, plus a note on their limits beyond obesity and diabetes care.
Recap by typeshit. Post by Facebook on Facebook.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The bid covers adults with BMI 30 or more, heart patients and teens. Korea's customs service caught 5,030 illegal obesity drug imports this year.
Medscape covers a new international consensus statement on how GLP-1 receptor agonists should be handled around pregnancy.
Loading…